AstraZeneca PLC
AZNAstraZeneca plc (/ˌæstrəˈzɛnəkə/) (AZ) is a Swedish-British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
Drugs in Pipeline
459
Phase 3 Programs
262
Upcoming Catalysts
71
Next Catalyst
Apr 29, 2026
17dMarket Overview
Stock performance and key metrics
73 upcoming, 2 past
MEDI4736 + Tremelimumab
Recurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHN
5-fluorouracil ( in FOLFOX)
Colorectal Cancer
Quetiapine Fumarate Sustained Release
Major Depressive Disorder
Seroquel (quetiapine)
Schizophrenia
Epanova
Hypertriglyceridemia
MEDI4736 (durvalumab)
Non - Small Cell Lung Cancer NSCLC
Intralipid
Sedation to be Moderate for a Diagnostic Gastrointestinal Endoscopy and Gastrointestinal Endoscopic Polypectomy
exenatide twice daily (BID)
Type 2 Diabetes Mellitus
BGF MDI HFO 320/14.4/9.6μg
COPD (Chronic Obstructive Pulmonary Disease)
Escitalopram oxylate
Generalized Anxiety Disorder
Thiazolidinedione (Pioglitazone)
Type 2 Diabetes
Extended release quetiapine (quetiapine XR)
Bipolar Disorder
quetiapine fumarate or valproate
Bipolar Disorder
Palbociclib
Locally Advanced (Inoperable) or Metastatic Breast Cancer
Roxadustat
Anemia
Anastrozole
Breast Cancer
Clopidogrel
Stable Coronary Artery Disease
Cisplatin + Gemcitabine
Unresectable Locally Advanced Urothelial Cancer
Omeprazole
Reflux Esophagitis
ABT-143
Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia
Acetylsalicylic acid ASA
Acute Coronary Syndrome
ZD4054
Prostate Cancer
Rosuvastatin
Hypercholesterolemia
Capivasertib
Triple Negative Breast Neoplasms
corn oil control
Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Docetaxel
Prostate Cancer
Esomeprazole magnesium (Nexium)
Zollinger-Ellison Syndrome
Mepolizumab
Eosinophilic Granulomatous Vasculitis
Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate
Chronic Obstructive Pulmonary Disease
Dapagliflozin 10 mg
Diabetes Mellitus, Non-Insulin-Dependent
Dapagliflozin 5 mg
Type 1 Diabetes Mellitus
Conventional Asthma Therapy
Asthma
Pemetrexed/Carboplatin
Non-Small Cell Lung Cancer
pravastatin
Hyperlipoproteinemia Type III
Symbicort
COPD Patients
candesartan cilexetil (Atacand)
Hypertension
AZD1222
COVID-19
quetiapine fumarate tablets
Schizophrenia
Benralizumab
Asthma
Durvalumab + SoC chemotherapy
Carcinoma, Non-Small-Cell Lung
exenatide
Type 2 Diabetes Mellitus
ZD1839 (Gefitinib)
Carcinoma
fluticasone/salmeterol (Advair)
Asthma
exemestane
Progression-free Survival
Amitriptyline
Major Depressive Disorder
exenatide twice daily
Type 2 Diabetes Mellitus
faslodex 500mg
Hormone Receptor Positive Breast Cancer
Single agent chemotherapy
Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
Sodium Zirconium Cyclosilicate (ZS) 10g
Hyperkalemia
Carboplatin+Paclitaxel
Advanced Ovarian Cancer
Formoterol Turbuhaler® 4.5mg
Chronic Obstructive Pulmonary Disease
Olaparib 300mg tablets
Relapsed Ovarian Cancer
Aclidinium Bromide / Formoterol Fumarate
Chronic Obstructive Pulmonary Disease (COPD)
Oleclumab
Non-Small Cell Lung Cancer
Ciclesonide nasal
Rhinitis, Allergic, Perennial
Active Comparator: Olaparib tablets
Epithelial Ovarian Cancer
Aclidinium bromide
Chronic Obstructive Pulmonary Disease (COPD)
NKTR-118
Opioid-Induced Constipation (OIC)
MEDI8897
Respiratory Syncytial Virus Infections
Carboplatin
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Saxagliptin, 5 mg + insulin
Type 2 Diabetes
Osimertinib 80mg/40mg
Non Small Cell Lung Cancer (Stage III)
Zirconium Cyclosilicate
Hyperkalemia
Cediranib
Metastatic Colorectal Cancer
Exenatide (AC2993)
Diabetes Mellitus, Type 2
Sodium Zirconium Cyclosilicate (ZS)
Hyperkalemia
Gefitinib
Non-Small Cell Lung Cancer
Lomustine Chemotherapy
Recurrent Glioblastoma
Tremelimumab
Advanced Hepatocellular Carcinoma
HFO-1234ze(E)
Mucociliary Clearance
Simvastatin
Fredrickson Type IIa & Type IIb Dyslipidaemia
AZD2816
COVID-19
Ezetimibe
Hypercholesterolemia
Rosuvastatin Dose 1
Dyslipidaemia
Roflumilast
Chronic Obstructive Pulmonary Disease (COPD)
Aclidinium Bromide/Formoterol Fumarate
Chronic Obstructive Pulmonary Disease
Aclidinium Bromide 200 µg
Chronic Obstructive Pulmonary Disease
Osimertinib
Lung Cancer
Budesonide HFA
Asthma
Symbicort pMDI
Asthma
Acalabrutinib
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Bicalutamide
Puberty, Precocious
Seroquel SR
Schizophrenia
Esomeprazole
NSAID Associated Gastric Ulcers
Tiotropium
Chronic Obstructive Pulmonary Disease (COPD)
Anifrolumab
Lupus Nephritis
Savolitinib
Carcinoma
Budesonide/formoterol Turbuhaler vs Conventional Best Asthma Therapy
Asthma
Tamoxifen
Quality of Life
pioglitazone
Diabetes
Aclidinium bromide 200 μg bid
Chronic Obstructive Pulmonary Disease (COPD)
Terbutaline sulphate
Asthma
Exantide with Dapagliflozin
Diabetes Mellitus
quetiapine fumarate (Seroquel)
Bipolar Disorder
Epoetin alfa
Anemia
Sodium Zirconium Cyclosilicate
Hyperkalemia
AZD5335
Epithelial Ovarian Cancer
Pramlintide acetate
Diabetes Mellitus, Type 1
divalproex
Bipolar I Disorder
budesonide (Pulmicort)
Asthma
Rosuvastatin calcium
Hypercholesteremia
tralokinumab
Ulcerative Colitis
Durvalumab
Non-Small Cell Lung Cancer
Budesonide/formoterol (SYMBICORT) pMDI
Chronic Obstructive Pulmonary Disease
Tozorakimab
Chronic Obstructive Pulmonary Disease (COPD)
Quetiapine Fumarate
Bipolar Disorder
Zolmitriptan
Migraine
Salmeterol/fluticasone Diskus
Asthma
Quetiapine Fumarate (SEROQUEL) Extended-Release (XR)
Schizophrenia
Quetiapine
Major Depressive Disorder
MEDI3250
Healthy Japanese Children Age 7 Years Through 18 Years
AZD0780
Heterozygous Familial Hypercholesterolaemia
exenatide/insulin glargine
Type 2 Diabetes Mellitus
Selumetinib
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
Glimepiride
Type 2 Diabetes
Metformin (blinded)
Type 2 Diabetes
Candesartan
Congestive Heart Failure
Ranitidine
Gastric Ulcer
Atorvastatin
Coronary Atherosclerosis
Ciclesonide
Perennial Allergic Rhinitis
lithium
Bipolar I Disorder
metoprolol succinate
Hypertension
Aclidinium bromide 400 μg/Formoterol Fumarate 12 μg (AB/FF 400/12 μg)
Chronic Obstructive Pulmonary Disease
Hydrochlorothiazide
Hypertension
Exenatide once weekly suspension
Diabetes Mellitus, Type 2
Experimental: Tezepelumab
Chronic Rhinosinusitis With Nasal Polyps
Baxdrostat
Resistant Hypertension
TC-5214
Major Depressive Disorder
Tezepelumab
Moderate to Severe Asthma
budesonode bid + terbutaline 'as needed'
Asthma
Symbicort pMDI + budesonide HFA pMDI
Asthma
Olanzapine, risperidone
Schizophrenia
insulin lispro
Type 2 Diabetes Mellitus
AZD9833
ER-Positive HER2-Negative Breast Cancer
Medi-546
Systemic Lupus Erythematosus
Benralizumab Arm A
Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Metformin immediate release (IR)
Type 2 Diabetes
Saxagliptin plus metformin IR
Type 2 Diabetes Mellitus
Symbicort TBH - Turbuhaler
Asthma
formoterol
Asthma
10mg Rosuvastatin
Renal Failure
Olive oil, 4g
Hypertriglyceridemia
Dapagliflozin
Heart Failure With Reduced Ejection Fraction (HFrEF)
Saxagliptin
Type 2 Diabetes
Budesonide HFA pMDI
Asthma
Fluticasone
Asthma
AZD9291 Dosing
Lung Cancer
budesonide
Asthma
Gefitinib (Iressa)
Cancer
Benralizumab Arm B
Moderate to Very Severe Chronic Obstructive Pulmonary Disease
MEDI4736
Squamous Cell Carcinoma of the Head and Neck
Metformin
Type 2 Diabetes Mellitus
Candesartan cilexetil
Hypertension
budesonide bid + terbutaline 'as needed'
Asthma
BCG
Non-Muscle- Invasive Bladder Cancer
Durvalumab (MEDI4736)
Non-muscle-invasive Bladder Cancer
Etoposide
Extensive-stage Small Cell Lung Cancer
exenatide, long acting release
Type 2 Diabetes Mellitus
glipizide
Type 2 Diabetes
Pemetrexed
Non-Small Cell Lung Cancer
Fulvestrant
Breast Cancer
Terbutaline Turbuhaler®
Asthma
Rosuvastatin (Crestor)
Hypercholesterolemia
Osimertinib (AZD9291) pemetrexed cisplatin or carboplatin
Non-small Cell Lung Cancer
Linaclotide
Irritable Bowel Syndrome With Constipation (IBS-C)
Enfortumab Vedotin
Muscle Invasive Bladder Cancer
Budesonide/albuterol metered-dose inhaler 160/180 μg
Asthma, Exercise-Induced
Quetiapine fumarate (Seroquel) SR
Affective Psychosis, Bipolar
(Osimertinib cohort, single-arm, open-label separate cohort)
Carcinoma, Non-Small-Cell Lung
BFF MDI 320/9.6 μg
Asthma
Paclitaxel
Metastatic Non-small Cell Lung Cancer
Seroquel®, quetiapine fumarate (atypical antipsychotic)
Bipolar Disorder
Budesonide/formoterol pMDI
Asthma
CRESTOR
Heart Failure
Gemcitabine
Biliary Tract Cancer
Quetiapine Fumarate (Seroquel™) drug, mood stabilizer (mood)
Bipolar Disorder
Pertuzumab
Breast Neoplasms
cisplatin + fluorouracil
Esophageal Squamous Cell Carcinoma
Ciclesonide nasal spray
Hay Fever
BGF MDI 320/28.8/9.6 μg
Asthma
Letrozole
Breast Cancer, Early Breast Cancer
Tezepelumab (APFS)
Asthma
Sitagliptin
Type 2 Diabetes
BGF MDI HFO 320/14.4/9.6 μg
Chronic Obstructive Pulmonary Disease (COPD)
AZD7442
COVID-19
Datopotamab deruxtecan (Dato-DXd)
Non-small Cell Lung Cancer (NSCLC)
AZD4831
Heart Failure With Preserved Ejection Fraction
Ticagrelor
Acute Coronary Syndrome
Saxagliptin 5mg
Type 2 Diabetes Mellitus
Volrustomig
Non-small Cell Lung Cancer
Seasonal influenza virus vaccine
Asthma
Epanova® (omega-3 carboxylic acids)
Diabetes Mellitus, Type 2
Rosuvastatin 20mg
Homozygous Familial Hypercholesterolemia (HoFH)
Casdatifan
Advanced Clear Cell Renal Cell Carcinoma
D961H capsule 10mg
Reflux Esophagitis
exenatide once weekly
Type 2 Diabetes Mellitus
AZD1152
Acute Myeloid Leukemia
Gefitinib, raltitrexed
Colorectal Cancer
Salbutamol
Asthma
Zibotentan/Dapagliflozin
Chronic Kidney Disease With High Proteinuria
ABT-335 plus rosuvastatin
Dyslipidemia
Esomeprazole 20 mg
Gastric Ulcer
Acetylsalicylic acid (ASA)
Acute Ischaemic Stroke
ATACAND
Hypertension
AC2993
Diabetes Mellitus, Type 2
Symbicort Turbuhaler
Bronchial Asthma
Budesonide/Formoterol
Asthma
Chemotherapy
Anticancer Treatment
Baxdrostat/dapagliflozin
Chronic Kidney Disease and Hypertension
rosiglitazone
Diabetes Mellitus, Type 2
Durvalumab plus chemotherapy
Small Cell Lung Carcinoma Extensive Disease
Quetiapine Fumarate Extended- Release
Schizophrenia
Insulin glargine
Type 2 Diabetes Mellitus
AZD5156 (Parent study Sentinel Safety Cohort)
COVID-19, SARS-CoV-2
Sodium Zirconium Cyclosilicate (SZC) Reduced Dose Level
Hyperkalaemia
Saruparib
Prostate Cancer
5-fluorouracil
Colorectal Cancer
Sulphonylurea
Type 2 Diabetes
Saxagliptin 2.5 mg
Type 2 Diabetes Mellitus, CKD and Albuminuria
Oxaliplatin
HER2-positive Gastric Cancer
Saxagliptin + Metformin
Diabetes Mellitus, Type 2
Nirsevimab
Respiratory Syncytial Virus Infections
Quetiapine XR
Major Depressive Disorder
budesonide/formoterol (Symbicort)
Asthma
quetiapine fumarate XR
Anxiety
candsartan cilexetil
Hypertension
ZD9393 (Zoladex) 10.8 mg
Breast Cancer
Saruparib (AZD5305)
Ovarian Cancer
Esomeprazole IV
Gastrointestinal Hemorrhage
Gemcitabine/Cisplatin
Biliary Tract Cancer
Datopotamab Deruxtecan
Non-small Cell Lung Cancer
Saxagliptin 5 mg
Type 2 Diabetes Mellitus
Nexium 20mg
Erosive Esophagitis
Quetiapine SR
Major Depressive Disorder
Pulmicort (budesonide) Respules
Asthma
Olaparib
Breast Cancer Metastatic
sunitinib
Papillary Renal Cell Carcinoma
Eplontersen
Transthyretin Amyloid Cardiomyopathy
D9421-C capsule 3 mg
Crohn's Disease
Capecitabine
Advanced or Metastatic Breast Cancer
omefas
Severe Hypertriglyceridemia
Saxagliptin, Onglyza
Type 2 Diabetes Mellitus
Pulmicort Turbuhaler
Asthma
Camizestrant
Advanced Breast Cancer
Benralizumab (Medi-563)
Asthma
Abiraterone Acetate
Hormone-Sensitive Prostate Cancer
Cimetidine
Stress Ulcer Prophylaxis
Ticagrelor 60 mg
Diabetes Mellitus, Type 2
Lithium carbonate
Acute Bipolar Depression
Metformin XR
Type 2 Diabetes
Esomeprazole (D961H) twice daily
Refractory Reflux Esophagitis
Gemcitabine monotherapy
Biliary Tract Cancer
Theophylline
Asthma
Dato-DXd
Breast Cancer
Anastrazole (Arimidex)
Breast Cancer
Cisplatin
Muscle Invasive Bladder Cancer
FLOT chemotherapy
Gastrointestinal Neoplasms
Budesonide/formoterol Turbuhaler
Asthma
ABT-335 and rosuvastatin calcium
Hypercholesterolemia
SSRI/Clomipramine
Obsessive Compulsive Disorder
Rilvegostomig
Hepatocellular Carcinoma
Daptomycin
Skin Diseases
AZD2624
Schizophrenia
AC2993 (exenatide)
Diabetes Mellitus
AZD6234
Obesity/Overweight
MEDI6570
Coronary Heart Disease (CHD)
Tremelimumab monotherapy
Urothelial Bladder Cancer
B - Exenatide 10 mcg twice daily
Diabetes Mellitus, Type 2
ZD1839
Mesothelioma
Ticagrelor Dose 1a + Dose 2a
Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease
AZD3470
Lymphoma
AZD1940
Pain
AZD9793 Intravenous (IV) monotherapy
Hepatocellular Carcinoma
Anastrazole
Breast Cancer
AZD2927
Arrhythmia
cediranib and olaparib
Recurrent Platinum Resistant Ovarian Cancer
AZD0022
Advanced Solid Tumours
lesogaberan (AZD3355)
Gastroesophageal Reflux Disease
pramlintide acetate 360 mcg
Overweight
AZD5363 when combined with weekly paclitaxel.
Advanced or Metastatic Breast Cancer
AZD1305
Atrial Fibrillation
AZD9056
Rheumatoid Arthritis
Casodex
Gynaecomastia
Lenvatinib
Hepatocellular Carcinoma
AZD5423
Chronic Obstructive Pulmonary Disease (COPD)
Ticagrelor Tablets
Coronary Artery Disease
Formoterol Fumarate in the Pressair DPI, Low Dose
Asthma
KU-0059436 (AZD2281)(PARP inhibitor)
Ovarian Neoplasm
AZD5492
B-cell Malignancies
Part A:AZD8233
Dyslipidemia
Montelukast
Asthma
AZD5851
Hepatocellular Carcinoma
AZD2423
Chronic Obstructive Pulmonary Disease
Ceralasertib
Advanced Solid Tumours
AC2993 2.5 mcg
Diabetes Mellitus, Non-Insulin-Dependent
AZD3480
ADHD
Biological: AZD3152
COVID-19, SARS-CoV-2
AZD4117
Influenza A
Aclidinium bromide 100 μg bid
Chronic Obstructive Pulmonary Disease (COPD)
AC2592
Congestive Heart Failure
AZD7325
Anxiety Disorders
AZD5462
Chronic Heart Failure
AZD8630
Asthma
AZD2389
Liver Fibrosis
ER tablet 25 mg AZD3241
Parkinson's Disease
Gefitinib, radiotherapy
Non-Metastatic Prostate Cancer
AZD9773 (CytoFab)
Severe Sepsis
Cediranib 30 - 90 mg
Cancer
AZD3427
Pulmonary Hypertension (World Health Organization Group 2)
AZD6765
Treatment Resistant Major Depressive Disorder
Omega-3 carboxylic acid
Non-alcoholic Fatty Liver Disease (NAFLD
terbutaline
Exercise Induced Asthma
Gefitinib and capecitabine
Colorectal Cancer
Anastrozole (ARIMIDEX™)
Gynecomastia
AB248
Advanced or Metastatic Non-small Cell Lung Cancer
AZD2066
Reflux Episodes
Goserelin acetate
Advanced Breast Cancer
AZD8233
Hyperlipidaemia
AZD3241 300 mg BID
Parkinson's Disease
AZD6750
Melanoma
AS MDI
Asthma
Adavosertib
Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
AZD9567
Diabetes Mellitus, Type 2
AZD9668
Chronic Obstructive Pulmonary Disease
AZD6621
Prostate Cancer
AZD8601
Heart Failure
AZD6094
Papillary Renal Cell Cancer
AZD3199
COPD
AC2307
Obesity
AZD5213
Mild Cognitive Impairment
Administration of ceralasertib
Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
AZD4604
Asthma
AZD6244
Non Small Cell Lung Cancer
RDEA3170
Gout and Hyperuricemia
AZD9550
Overweight and Obesity
AZD2115
COPD
600 mg AZD7442 IV
Coronavirus Disease 2019 (COVID-19)
ZD4054 10 mg
Prostatic Neoplasms
AZD0837
Nonvalvular Atrial Fibrillation
Irinotecan
Colorectal Cancer
AZD9150
Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck
AZD8205
Breast Cancer
Leucovorin LV
Endometrial Cancer
gefitinib and fulvestrant
Breast Cancer
AZD7760
Staphylococcus Aureus
Ramucirumab
Non-Small Cell Lung Cancer
AZD4573
Advanced Haematological Malignancies
MEDI0382 low dose
Diabetes Mellitus, Type 2
AZD0754
Metastatic Prostate Cancer
AZD5069
Asthma
AZD8683, 50 mcg
Chronic Obstructive Pulmonary Disease (COPD)
AZD9574
Advanced Solid Malignancies
Formoterol fumarate (6 μg)
Chronic Obstructive Pulmonary Disease - COPD
Osimertinib 80 mg/40 mg
Stage II-IIIB Non-small Cell Lung Carcinoma
ZD1839 (IRESSA™)
Head and Neck Cancer
Exenatide LAR
Type 2 Diabetes Mellitus
plevitrexed
Fallopian Tube Cancer
AZD1981
Asthma
AZD0865
GERD Without Erosive Esophagitis
Atuliflapon
Asthma
AZD7789
Carcinoma, Non-Small-Cell Lung
Aclidinium 400 μg / Formoterol 12 μg
Chronic Obstructive Pulmonary Disease
MEDI3506
Atopic Dermatitis
NXY-059
Intracerebral Hemorrhage
CP-675,206
Malignant Melanoma
GC012F (AZD0120)
Relapsed/ Refractory Multiple Myeloma
AZD8848
Allergic Asthma
AZD7594 DPI 55μg/50μg.
Asthma
Iressa
Locally Advanced Prostate Cancer
AZD9164
Chronic Obstructive Pulmonary Disease
AZD2936
Non-Small-Cell Lung Carcinoma
AZD2281
Ovarian Neoplasms
80/2.25 μg Symbicort pMDI
Asthma
Anastrozole and goserelin
Breast Cancer
AZD4360
Gastric Cancer
Selumetinib 75 mg
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
Aclidinium/formoterol 400/12μg
Chronic Obstructive Pulmonary Disease (COPD)
MEDI4736 monotherapy
Metastatic Pancreatic Ductal Adenocarcinoma
Abiraterone
Metastatic Castration-resistant Prostate Cancer
IR (Immediate-Release) quetiapine fumarate (drug)
Schizophrenia
Mitiperstat (AZD4831)
Chronic Obstructive Pulmonary Disease (COPD)
AZD7798
Crohn's Disease
Insulin
Type 2 Diabetes Mellitus
Fluorouracil (5-FU)
Gastric Cancer
AS MDI 90 μg
Asthma
D9421-C, 9mg
Crohn's Disease
AZD 8529
Schizophrenia
5-flourouracil
Squamous Cell Cancer
AZD4635
Prostate Cancer
5-Fluorouracil (5-FU)
Gastroesophageal Adenocarcinoma
Danvatirsen
Non-Small Cell Lung Cancer
AZD9291
Advanced Non Small Cell Lung Cancer
MEDI2070
Crohn's Disease
Temozolomide
Melanoma
AZD3355
GERD
ICI35,868 (propofol)
Gastrointestinal Endoscopy
Ciclesonide/Formoterol Combination
Asthma
Olaparib Continuous (28-Day cycle) 300 mg BD.
Metastatic Triple Negative Breast Cancer
fostamatinib
Rheumatoid Arthritis
AZD7009, no generic name available
Atrial Fibrillation
AZD5069 50mg
Scientific Terminology Chronic Obstructive Pulmonary Disease (COPD)
AZD0901
Gastric Cancer
AZD1446
Adult ADHD
Salmeterol
Chronic Obstructive Pulmonary Disease
Neoadjuvant Olaparib monotherapy group
Breast Cancer
AZD9829
Hematological Malignancies
AZD5004
Diabetes Mellitus, Type 2
LAS100977 0.313 μg
Asthma
AZD9773
Severe Sepsis
Cotadutide
Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
AZD2171
Metastatic Colorectal Cancer
sibutramine
Overweight
Sodium Zirconium Cyclosilicate(ZS)
Hyperkalemia
AZD8931
Neoplasms
AZD4017
Raised Intraocular Pressure
Interferon beta-1a Nebuliser solution 48 μg/mL
Asthma
FOLFIRI (Fluorouracil (5-FU), leucovorin, irinotecan)
Metastatic Colorectal Cancer
CIN-107
Uncontrolled Hypertension
budesonide/formoterol, 2x 200/6 microgram. 4 times daily
Chronic Obstructive Pulmonary Disease
Cotadutide 100 micrograms
Type 2 Diabetes Mellitus
Durvalumab and Tremelimumab
Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma
Aclidinium 200 μg / formoterol 12 μg
Chronic Obstructive Pulmonary Disease
Pramlintide and Metreleptin
Obesity
BMS-512148
Diabetes Mellitus, Type 2
AZD3241
Multiple System Atrophy, MSA
AZD2693
Nonalcoholic Steatohepatitis
AZD4901 (oral)
Polycystic Ovary Syndrome (PCOS), Female Endocrine Disorder
MEDI7352
Painful Osteoarthritis of the Knee
800 μg AZD7594 once daily
Asthma
MEDI-545
Systemic Lupus Erythematosus
AZD0120
Lupus Erythematosus, Systemic
AZD5718
Coronary Artery Disease
Verinurad 9 mg+Febuxostat 80 mg
Hyperuricemia
exenatide (LY2148568)
Type 2 Diabetes Mellitus
0.5% Roflumilast Cream
Atopic Dermatitis
Verinurad
Chronic Kidney Disease
AZD8871
Chronic Obstructive Pulmonary Disease
Epanova (4 g) and Lovaza (4 g)
Severe Hypertriglyceridemia
AZD2327
Anxious Major Depressive Disorder
AZD9977
Heart Failure
CP-675,206 and leuprolide acetate and bicalutamide
Prostatic Neoplasms
AZD0171
Locally Advanced or Metastatic Solid Tumours
Osimertinib + Savolitinib
Non-Small Cell Lung Cancer
AZD0530
Breast Cancer
AZD5305
Ovarian Cancer
AZD8871 100 µg
Chronic Obstructive Pulmonary Disease COPD
Vinorelbine
Non-Small Cell Lung Cancer
AZD7648
Advanced Malignancies
Gefitinib, Cisplatin and Radiotherapy
Cancer of Head and Neck
AZD4818
Chronic Obstructive Pulmonary Disease (COPD)
VKA INR 2-3
Persistent or Permanent Nonvalvular Atrial Fibrillation
AZD8421
ER+ HER2- Advanced Breast Cancer
AZD1656
Type 2 Diabetes Mellitus
AZD4512
B-cell Non-Hodgkin Lymphoma
Surovatamig
B-cell Non-Hodgkin Lymphoma
Tiotropium 18 μg once-daily
Chronic Obstructive Pulmonary Disease (COPD)
Monalizumab
Non-small Cell Lung Cancer
AZD0486
Chronic Lymphocytic Leukaemia
AZD1163
Rheumatoid Arthritis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
MEDI4736 + Tremelimumab | Phase 3 | Recurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHN | - | - |
5-fluorouracil ( in FOLFOX) | Phase 3 | Colorectal Cancer | - | - |
Quetiapine Fumarate Sustained Release | Phase 3 | Major Depressive Disorder | - | - |
Seroquel (quetiapine) | Phase 3 | Schizophrenia | - | - |
Epanova | Phase 3 | Hypertriglyceridemia | - | - |
MEDI4736 (durvalumab) | Phase 3 | Non - Small Cell Lung Cancer NSCLC | - | - |
Intralipid | Phase 3 | Sedation to be Moderate for a Diagnostic Gastrointestinal Endoscopy and Gastrointestinal Endoscopic Polypectomy | - | - |
exenatide twice daily (BID) | Phase 3 | Type 2 Diabetes Mellitus | - | - |
BGF MDI HFO 320/14.4/9.6μg | Phase 3 | COPD (Chronic Obstructive Pulmonary Disease) | - | - |
Escitalopram oxylate | Phase 3 | Generalized Anxiety Disorder | - | - |
Thiazolidinedione (Pioglitazone) | Phase 3 | Type 2 Diabetes | - | - |
Extended release quetiapine (quetiapine XR) | Phase 3 | Bipolar Disorder | - | - |
quetiapine fumarate or valproate | Phase 3 | Bipolar Disorder | - | - |
Palbociclib | Phase 3 | Locally Advanced (Inoperable) or Metastatic Breast Cancer | - | - |
Roxadustat | Phase 3 | Anemia | - | - |
Anastrozole | Phase 3 | Breast Cancer | - | - |
Clopidogrel | Phase 3 | Stable Coronary Artery Disease | - | - |
Cisplatin + Gemcitabine | Phase 3 | Unresectable Locally Advanced Urothelial Cancer | - | - |
Omeprazole | Phase 3 | Reflux Esophagitis | - | - |
ABT-143 | Phase 3 | Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia | - | - |
Acetylsalicylic acid ASA | Phase 3 | Acute Coronary Syndrome | - | - |
ZD4054 | Phase 3 | Prostate Cancer | - | - |
Rosuvastatin | Phase 3 | Hypercholesterolemia | - | - |
Capivasertib | Phase 3 | Triple Negative Breast Neoplasms | - | - |
corn oil control | Phase 3 | Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD) | - | - |
Docetaxel | Phase 3 | Prostate Cancer | - | - |
Esomeprazole magnesium (Nexium) | Phase 3 | Zollinger-Ellison Syndrome | - | - |
Mepolizumab | Phase 3 | Eosinophilic Granulomatous Vasculitis | - | - |
Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Dapagliflozin 10 mg | Phase 3 | Diabetes Mellitus, Non-Insulin-Dependent | - | - |
Dapagliflozin 5 mg | Phase 3 | Type 1 Diabetes Mellitus | - | - |
Conventional Asthma Therapy | Phase 3 | Asthma | - | - |
Pemetrexed/Carboplatin | Phase 3 | Non-Small Cell Lung Cancer | - | - |
pravastatin | Phase 3 | Hyperlipoproteinemia Type III | - | - |
Symbicort | Phase 3 | COPD Patients | - | - |
candesartan cilexetil (Atacand) | Phase 3 | Hypertension | - | - |
AZD1222 | Phase 3 | COVID-19 | - | - |
quetiapine fumarate tablets | Phase 3 | Schizophrenia | - | - |
Benralizumab | Phase 3 | Asthma | - | - |
Durvalumab + SoC chemotherapy | Phase 3 | Carcinoma, Non-Small-Cell Lung | - | - |
exenatide | Phase 3 | Type 2 Diabetes Mellitus | - | - |
ZD1839 (Gefitinib) | Phase 3 | Carcinoma | - | - |
fluticasone/salmeterol (Advair) | Phase 3 | Asthma | - | - |
exemestane | Phase 3 | Progression-free Survival | - | - |
Amitriptyline | Phase 3 | Major Depressive Disorder | - | - |
exenatide twice daily | Phase 3 | Type 2 Diabetes Mellitus | - | - |
faslodex 500mg | Phase 3 | Hormone Receptor Positive Breast Cancer | - | - |
Single agent chemotherapy | Phase 3 | Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity | - | - |
Sodium Zirconium Cyclosilicate (ZS) 10g | Phase 3 | Hyperkalemia | - | - |
Carboplatin+Paclitaxel | Phase 3 | Advanced Ovarian Cancer | - | - |
Formoterol Turbuhaler® 4.5mg | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Olaparib 300mg tablets | Phase 3 | Relapsed Ovarian Cancer | - | - |
Aclidinium Bromide / Formoterol Fumarate | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Oleclumab | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Ciclesonide nasal | Phase 3 | Rhinitis, Allergic, Perennial | - | - |
Active Comparator: Olaparib tablets | Phase 3 | Epithelial Ovarian Cancer | - | - |
Aclidinium bromide | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
NKTR-118 | Phase 3 | Opioid-Induced Constipation (OIC) | - | - |
MEDI8897 | Phase 3 | Respiratory Syncytial Virus Infections | - | - |
Carboplatin | Phase 3 | Locally Advanced or Metastatic Non-Small Cell Lung Cancer | - | - |
Saxagliptin, 5 mg + insulin | Phase 3 | Type 2 Diabetes | - | - |
Osimertinib 80mg/40mg | Phase 3 | Non Small Cell Lung Cancer (Stage III) | - | - |
Zirconium Cyclosilicate | Phase 3 | Hyperkalemia | - | - |
Cediranib | Phase 3 | Metastatic Colorectal Cancer | - | - |
Exenatide (AC2993) | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Sodium Zirconium Cyclosilicate (ZS) | Phase 3 | Hyperkalemia | - | - |
Gefitinib | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Lomustine Chemotherapy | Phase 3 | Recurrent Glioblastoma | - | - |
Tremelimumab | Phase 3 | Advanced Hepatocellular Carcinoma | - | - |
HFO-1234ze(E) | Phase 3 | Mucociliary Clearance | - | - |
Simvastatin | Phase 3 | Fredrickson Type IIa & Type IIb Dyslipidaemia | - | - |
AZD2816 | Phase 3 | COVID-19 | - | - |
Ezetimibe | Phase 3 | Hypercholesterolemia | - | - |
Rosuvastatin Dose 1 | Phase 3 | Dyslipidaemia | - | - |
Roflumilast | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Aclidinium Bromide/Formoterol Fumarate | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Aclidinium Bromide 200 µg | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Osimertinib | Phase 3 | Lung Cancer | - | - |
Budesonide HFA | Phase 3 | Asthma | - | - |
Symbicort pMDI | Phase 3 | Asthma | - | - |
Acalabrutinib | Phase 3 | Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | - | - |
Bicalutamide | Phase 3 | Puberty, Precocious | - | - |
Seroquel SR | Phase 3 | Schizophrenia | - | - |
Esomeprazole | Phase 3 | NSAID Associated Gastric Ulcers | - | - |
Tiotropium | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Anifrolumab | Phase 3 | Lupus Nephritis | - | - |
Savolitinib | Phase 3 | Carcinoma | - | - |
Budesonide/formoterol Turbuhaler vs Conventional Best Asthma Therapy | Phase 3 | Asthma | - | - |
Tamoxifen | Phase 3 | Quality of Life | - | - |
pioglitazone | Phase 3 | Diabetes | - | - |
Aclidinium bromide 200 μg bid | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Terbutaline sulphate | Phase 3 | Asthma | - | - |
Exantide with Dapagliflozin | Phase 3 | Diabetes Mellitus | - | - |
quetiapine fumarate (Seroquel) | Phase 3 | Bipolar Disorder | - | - |
Epoetin alfa | Phase 3 | Anemia | - | - |
Sodium Zirconium Cyclosilicate | Phase 3 | Hyperkalemia | - | - |
AZD5335 | Phase 3 | Epithelial Ovarian Cancer | - | - |
Pramlintide acetate | Phase 3 | Diabetes Mellitus, Type 1 | - | - |
divalproex | Phase 3 | Bipolar I Disorder | - | - |
budesonide (Pulmicort) | Phase 3 | Asthma | - | - |
Rosuvastatin calcium | Phase 3 | Hypercholesteremia | - | - |
tralokinumab | Phase 3 | Ulcerative Colitis | - | - |
Durvalumab | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Budesonide/formoterol (SYMBICORT) pMDI | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Tozorakimab | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Quetiapine Fumarate | Phase 3 | Bipolar Disorder | - | - |
Zolmitriptan | Phase 3 | Migraine | - | - |
Salmeterol/fluticasone Diskus | Phase 3 | Asthma | - | - |
Quetiapine Fumarate (SEROQUEL) Extended-Release (XR) | Phase 3 | Schizophrenia | - | - |
Quetiapine | Phase 3 | Major Depressive Disorder | - | - |
MEDI3250 | Phase 3 | Healthy Japanese Children Age 7 Years Through 18 Years | - | - |
AZD0780 | Phase 3 | Heterozygous Familial Hypercholesterolaemia | - | - |
exenatide/insulin glargine | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Selumetinib | Phase 3 | Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV | - | - |
Glimepiride | Phase 3 | Type 2 Diabetes | - | - |
Metformin (blinded) | Phase 3 | Type 2 Diabetes | - | - |
Candesartan | Phase 3 | Congestive Heart Failure | - | - |
Ranitidine | Phase 3 | Gastric Ulcer | - | - |
Atorvastatin | Phase 3 | Coronary Atherosclerosis | - | - |
Ciclesonide | Phase 3 | Perennial Allergic Rhinitis | - | - |
lithium | Phase 3 | Bipolar I Disorder | - | - |
metoprolol succinate | Phase 3 | Hypertension | - | - |
Aclidinium bromide 400 μg/Formoterol Fumarate 12 μg (AB/FF 400/12 μg) | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Hydrochlorothiazide | Phase 3 | Hypertension | - | - |
Exenatide once weekly suspension | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Experimental: Tezepelumab | Phase 3 | Chronic Rhinosinusitis With Nasal Polyps | - | - |
Baxdrostat | Phase 3 | Resistant Hypertension | - | - |
TC-5214 | Phase 3 | Major Depressive Disorder | - | - |
Tezepelumab | Phase 3 | Moderate to Severe Asthma | - | - |
budesonode bid + terbutaline 'as needed' | Phase 3 | Asthma | - | - |
Symbicort pMDI + budesonide HFA pMDI | Phase 3 | Asthma | - | - |
Olanzapine, risperidone | Phase 3 | Schizophrenia | - | - |
insulin lispro | Phase 3 | Type 2 Diabetes Mellitus | - | - |
AZD9833 | Phase 3 | ER-Positive HER2-Negative Breast Cancer | - | - |
Medi-546 | Phase 3 | Systemic Lupus Erythematosus | - | - |
Benralizumab Arm A | Phase 3 | Moderate to Very Severe Chronic Obstructive Pulmonary Disease | - | - |
Metformin immediate release (IR) | Phase 3 | Type 2 Diabetes | - | - |
Saxagliptin plus metformin IR | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Symbicort TBH - Turbuhaler | Phase 3 | Asthma | - | - |
formoterol | Phase 3 | Asthma | - | - |
10mg Rosuvastatin | Phase 3 | Renal Failure | - | - |
Olive oil, 4g | Phase 3 | Hypertriglyceridemia | - | - |
Dapagliflozin | Phase 3 | Heart Failure With Reduced Ejection Fraction (HFrEF) | - | - |
Saxagliptin | Phase 3 | Type 2 Diabetes | - | - |
Budesonide HFA pMDI | Phase 3 | Asthma | - | - |
Fluticasone | Phase 3 | Asthma | - | - |
AZD9291 Dosing | Phase 3 | Lung Cancer | - | - |
budesonide | Phase 3 | Asthma | - | - |
Gefitinib (Iressa) | Phase 3 | Cancer | - | - |
Benralizumab Arm B | Phase 3 | Moderate to Very Severe Chronic Obstructive Pulmonary Disease | - | - |
MEDI4736 | Phase 3 | Squamous Cell Carcinoma of the Head and Neck | - | - |
Metformin | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Candesartan cilexetil | Phase 3 | Hypertension | - | - |
budesonide bid + terbutaline 'as needed' | Phase 3 | Asthma | - | - |
BCG | Phase 3 | Non-Muscle- Invasive Bladder Cancer | - | - |
Durvalumab (MEDI4736) | Phase 3 | Non-muscle-invasive Bladder Cancer | - | - |
Etoposide | Phase 3 | Extensive-stage Small Cell Lung Cancer | - | - |
exenatide, long acting release | Phase 3 | Type 2 Diabetes Mellitus | - | - |
glipizide | Phase 3 | Type 2 Diabetes | - | - |
Pemetrexed | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Fulvestrant | Phase 3 | Breast Cancer | - | - |
Terbutaline Turbuhaler® | Phase 3 | Asthma | - | - |
Rosuvastatin (Crestor) | Phase 3 | Hypercholesterolemia | - | - |
Osimertinib (AZD9291) pemetrexed cisplatin or carboplatin | Phase 3 | Non-small Cell Lung Cancer | - | - |
Linaclotide | Phase 3 | Irritable Bowel Syndrome With Constipation (IBS-C) | - | - |
Enfortumab Vedotin | Phase 3 | Muscle Invasive Bladder Cancer | - | - |
Budesonide/albuterol metered-dose inhaler 160/180 μg | Phase 3 | Asthma, Exercise-Induced | - | - |
Quetiapine fumarate (Seroquel) SR | Phase 3 | Affective Psychosis, Bipolar | - | - |
(Osimertinib cohort, single-arm, open-label separate cohort) | Phase 3 | Carcinoma, Non-Small-Cell Lung | - | - |
BFF MDI 320/9.6 μg | Phase 3 | Asthma | - | - |
Paclitaxel | Phase 3 | Metastatic Non-small Cell Lung Cancer | - | - |
Seroquel®, quetiapine fumarate (atypical antipsychotic) | Phase 3 | Bipolar Disorder | - | - |
Budesonide/formoterol pMDI | Phase 3 | Asthma | - | - |
CRESTOR | Phase 3 | Heart Failure | - | - |
Gemcitabine | Phase 3 | Biliary Tract Cancer | - | - |
Quetiapine Fumarate (Seroquel™) drug, mood stabilizer (mood) | Phase 3 | Bipolar Disorder | - | - |
Pertuzumab | Phase 3 | Breast Neoplasms | - | - |
cisplatin + fluorouracil | Phase 3 | Esophageal Squamous Cell Carcinoma | - | - |
Ciclesonide nasal spray | Phase 3 | Hay Fever | - | - |
BGF MDI 320/28.8/9.6 μg | Phase 3 | Asthma | - | - |
Letrozole | Phase 3 | Breast Cancer, Early Breast Cancer | - | - |
Tezepelumab (APFS) | Phase 3 | Asthma | - | - |
Sitagliptin | Phase 3 | Type 2 Diabetes | - | - |
BGF MDI HFO 320/14.4/9.6 μg | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
AZD7442 | Phase 3 | COVID-19 | - | - |
Datopotamab deruxtecan (Dato-DXd) | Phase 3 | Non-small Cell Lung Cancer (NSCLC) | - | - |
AZD4831 | Phase 3 | Heart Failure With Preserved Ejection Fraction | - | - |
Ticagrelor | Phase 3 | Acute Coronary Syndrome | - | - |
Saxagliptin 5mg | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Volrustomig | Phase 3 | Non-small Cell Lung Cancer | - | - |
Seasonal influenza virus vaccine | Phase 3 | Asthma | - | - |
Epanova® (omega-3 carboxylic acids) | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Rosuvastatin 20mg | Phase 3 | Homozygous Familial Hypercholesterolemia (HoFH) | - | - |
Casdatifan | Phase 3 | Advanced Clear Cell Renal Cell Carcinoma | - | - |
D961H capsule 10mg | Phase 3 | Reflux Esophagitis | - | - |
exenatide once weekly | Phase 3 | Type 2 Diabetes Mellitus | - | - |
AZD1152 | Phase 3 | Acute Myeloid Leukemia | - | - |
Gefitinib, raltitrexed | Phase 3 | Colorectal Cancer | - | - |
Salbutamol | Phase 3 | Asthma | - | - |
Zibotentan/Dapagliflozin | Phase 3 | Chronic Kidney Disease With High Proteinuria | - | - |
ABT-335 plus rosuvastatin | Phase 3 | Dyslipidemia | - | - |
Esomeprazole 20 mg | Phase 3 | Gastric Ulcer | - | - |
Acetylsalicylic acid (ASA) | Phase 3 | Acute Ischaemic Stroke | - | - |
ATACAND | Phase 3 | Hypertension | - | - |
AC2993 | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Symbicort Turbuhaler | Phase 3 | Bronchial Asthma | - | - |
Budesonide/Formoterol | Phase 3 | Asthma | - | - |
Chemotherapy | Phase 3 | Anticancer Treatment | - | - |
Baxdrostat/dapagliflozin | Phase 3 | Chronic Kidney Disease and Hypertension | - | - |
rosiglitazone | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Durvalumab plus chemotherapy | Phase 3 | Small Cell Lung Carcinoma Extensive Disease | - | - |
Quetiapine Fumarate Extended- Release | Phase 3 | Schizophrenia | - | - |
Insulin glargine | Phase 3 | Type 2 Diabetes Mellitus | - | - |
AZD5156 (Parent study Sentinel Safety Cohort) | Phase 3 | COVID-19, SARS-CoV-2 | - | - |
Sodium Zirconium Cyclosilicate (SZC) Reduced Dose Level | Phase 3 | Hyperkalaemia | - | - |
Saruparib | Phase 3 | Prostate Cancer | - | - |
5-fluorouracil | Phase 3 | Colorectal Cancer | - | - |
Sulphonylurea | Phase 3 | Type 2 Diabetes | - | - |
Saxagliptin 2.5 mg | Phase 3 | Type 2 Diabetes Mellitus, CKD and Albuminuria | - | - |
Oxaliplatin | Phase 3 | HER2-positive Gastric Cancer | - | - |
Saxagliptin + Metformin | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Nirsevimab | Phase 3 | Respiratory Syncytial Virus Infections | - | - |
Quetiapine XR | Phase 3 | Major Depressive Disorder | - | - |
budesonide/formoterol (Symbicort) | Phase 3 | Asthma | - | - |
quetiapine fumarate XR | Phase 3 | Anxiety | - | - |
candsartan cilexetil | Phase 3 | Hypertension | - | - |
ZD9393 (Zoladex) 10.8 mg | Phase 3 | Breast Cancer | - | - |
Saruparib (AZD5305) | Phase 3 | Ovarian Cancer | - | - |
Esomeprazole IV | Phase 3 | Gastrointestinal Hemorrhage | - | - |
Gemcitabine/Cisplatin | Phase 3 | Biliary Tract Cancer | - | - |
Datopotamab Deruxtecan | Phase 3 | Non-small Cell Lung Cancer | - | - |
Saxagliptin 5 mg | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Nexium 20mg | Phase 3 | Erosive Esophagitis | - | - |
Quetiapine SR | Phase 3 | Major Depressive Disorder | - | - |
Pulmicort (budesonide) Respules | Phase 3 | Asthma | - | - |
Olaparib | Phase 3 | Breast Cancer Metastatic | - | - |
sunitinib | Phase 3 | Papillary Renal Cell Carcinoma | - | - |
Eplontersen | Phase 3 | Transthyretin Amyloid Cardiomyopathy | - | - |
D9421-C capsule 3 mg | Phase 3 | Crohn's Disease | - | - |
Capecitabine | Phase 3 | Advanced or Metastatic Breast Cancer | - | - |
omefas | Phase 3 | Severe Hypertriglyceridemia | - | - |
Saxagliptin, Onglyza | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Pulmicort Turbuhaler | Phase 3 | Asthma | - | - |
Camizestrant | Phase 3 | Advanced Breast Cancer | - | - |
Benralizumab (Medi-563) | Phase 3 | Asthma | - | - |
Abiraterone Acetate | Phase 3 | Hormone-Sensitive Prostate Cancer | - | - |
Cimetidine | Phase 3 | Stress Ulcer Prophylaxis | - | - |
Ticagrelor 60 mg | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Lithium carbonate | Phase 3 | Acute Bipolar Depression | - | - |
Metformin XR | Phase 3 | Type 2 Diabetes | - | - |
Esomeprazole (D961H) twice daily | Phase 3 | Refractory Reflux Esophagitis | - | - |
Gemcitabine monotherapy | Phase 3 | Biliary Tract Cancer | - | - |
Theophylline | Phase 3 | Asthma | - | - |
Dato-DXd | Phase 3 | Breast Cancer | - | - |
Anastrazole (Arimidex) | Phase 3 | Breast Cancer | - | - |
Cisplatin | Phase 3 | Muscle Invasive Bladder Cancer | - | - |
FLOT chemotherapy | Phase 3 | Gastrointestinal Neoplasms | - | - |
Budesonide/formoterol Turbuhaler | Phase 3 | Asthma | - | - |
ABT-335 and rosuvastatin calcium | Phase 3 | Hypercholesterolemia | - | - |
SSRI/Clomipramine | Phase 3 | Obsessive Compulsive Disorder | - | - |
Rilvegostomig | Phase 3 | Hepatocellular Carcinoma | - | - |
Daptomycin | Phase 3 | Skin Diseases | - | - |
AZD2624 | Phase 2 | Schizophrenia | - | - |
AC2993 (exenatide) | Phase 2 | Diabetes Mellitus | - | - |
AZD6234 | Phase 2 | Obesity/Overweight | - | - |
MEDI6570 | Phase 2 | Coronary Heart Disease (CHD) | - | - |
Tremelimumab monotherapy | Phase 2 | Urothelial Bladder Cancer | - | - |
B - Exenatide 10 mcg twice daily | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
ZD1839 | Phase 2 | Mesothelioma | - | - |
Ticagrelor Dose 1a + Dose 2a | Phase 2 | Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease | - | - |
AZD3470 | Phase 2 | Lymphoma | - | - |
AZD1940 | Phase 2 | Pain | - | - |
AZD9793 Intravenous (IV) monotherapy | Phase 2 | Hepatocellular Carcinoma | - | - |
Anastrazole | Phase 2 | Breast Cancer | - | - |
AZD2927 | Phase 2 | Arrhythmia | - | - |
cediranib and olaparib | Phase 2 | Recurrent Platinum Resistant Ovarian Cancer | - | - |
AZD0022 | Phase 2 | Advanced Solid Tumours | - | - |
lesogaberan (AZD3355) | Phase 2 | Gastroesophageal Reflux Disease | - | - |
pramlintide acetate 360 mcg | Phase 2 | Overweight | - | - |
AZD5363 when combined with weekly paclitaxel. | Phase 2 | Advanced or Metastatic Breast Cancer | - | - |
AZD1305 | Phase 2 | Atrial Fibrillation | - | - |
AZD9056 | Phase 2 | Rheumatoid Arthritis | - | - |
Casodex | Phase 2 | Gynaecomastia | - | - |
Lenvatinib | Phase 2 | Hepatocellular Carcinoma | - | - |
AZD5423 | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Ticagrelor Tablets | Phase 2 | Coronary Artery Disease | - | - |
Formoterol Fumarate in the Pressair DPI, Low Dose | Phase 2 | Asthma | - | - |
KU-0059436 (AZD2281)(PARP inhibitor) | Phase 2 | Ovarian Neoplasm | - | - |
AZD5492 | Phase 2 | B-cell Malignancies | - | - |
Part A:AZD8233 | Phase 2 | Dyslipidemia | - | - |
Montelukast | Phase 2 | Asthma | - | - |
AZD5851 | Phase 2 | Hepatocellular Carcinoma | - | - |
AZD2423 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
Ceralasertib | Phase 2 | Advanced Solid Tumours | - | - |
AC2993 2.5 mcg | Phase 2 | Diabetes Mellitus, Non-Insulin-Dependent | - | - |
AZD3480 | Phase 2 | ADHD | - | - |
Biological: AZD3152 | Phase 2 | COVID-19, SARS-CoV-2 | - | - |
AZD4117 | Phase 2 | Influenza A | - | - |
Aclidinium bromide 100 μg bid | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
AC2592 | Phase 2 | Congestive Heart Failure | - | - |
AZD7325 | Phase 2 | Anxiety Disorders | - | - |
AZD5462 | Phase 2 | Chronic Heart Failure | - | - |
AZD8630 | Phase 2 | Asthma | - | - |
AZD2389 | Phase 2 | Liver Fibrosis | - | - |
ER tablet 25 mg AZD3241 | Phase 2 | Parkinson's Disease | - | - |
Gefitinib, radiotherapy | Phase 2 | Non-Metastatic Prostate Cancer | - | - |
AZD9773 (CytoFab) | Phase 2 | Severe Sepsis | - | - |
Cediranib 30 - 90 mg | Phase 2 | Cancer | - | - |
AZD3427 | Phase 2 | Pulmonary Hypertension (World Health Organization Group 2) | - | - |
AZD6765 | Phase 2 | Treatment Resistant Major Depressive Disorder | - | - |
Omega-3 carboxylic acid | Phase 2 | Non-alcoholic Fatty Liver Disease (NAFLD | - | - |
terbutaline | Phase 2 | Exercise Induced Asthma | - | - |
Gefitinib and capecitabine | Phase 2 | Colorectal Cancer | - | - |
Anastrozole (ARIMIDEX™) | Phase 2 | Gynecomastia | - | - |
AB248 | Phase 2 | Advanced or Metastatic Non-small Cell Lung Cancer | - | - |
AZD2066 | Phase 2 | Reflux Episodes | - | - |
Goserelin acetate | Phase 2 | Advanced Breast Cancer | - | - |
AZD8233 | Phase 2 | Hyperlipidaemia | - | - |
AZD3241 300 mg BID | Phase 2 | Parkinson's Disease | - | - |
AZD6750 | Phase 2 | Melanoma | - | - |
AS MDI | Phase 2 | Asthma | - | - |
Adavosertib | Phase 2 | Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation | - | - |
AZD9567 | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
AZD9668 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
AZD6621 | Phase 2 | Prostate Cancer | - | - |
AZD8601 | Phase 2 | Heart Failure | - | - |
AZD6094 | Phase 2 | Papillary Renal Cell Cancer | - | - |
AZD3199 | Phase 2 | COPD | - | - |
AC2307 | Phase 2 | Obesity | - | - |
AZD5213 | Phase 2 | Mild Cognitive Impairment | - | - |
Administration of ceralasertib | Phase 2 | Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer | - | - |
AZD4604 | Phase 2 | Asthma | - | - |
AZD6244 | Phase 2 | Non Small Cell Lung Cancer | - | - |
RDEA3170 | Phase 2 | Gout and Hyperuricemia | - | - |
AZD9550 | Phase 2 | Overweight and Obesity | - | - |
AZD2115 | Phase 2 | COPD | - | - |
600 mg AZD7442 IV | Phase 2 | Coronavirus Disease 2019 (COVID-19) | - | - |
ZD4054 10 mg | Phase 2 | Prostatic Neoplasms | - | - |
AZD0837 | Phase 2 | Nonvalvular Atrial Fibrillation | - | - |
Irinotecan | Phase 2 | Colorectal Cancer | - | - |
AZD9150 | Phase 2 | Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck | - | - |
AZD8205 | Phase 2 | Breast Cancer | - | - |
Leucovorin LV | Phase 2 | Endometrial Cancer | - | - |
gefitinib and fulvestrant | Phase 2 | Breast Cancer | - | - |
AZD7760 | Phase 2 | Staphylococcus Aureus | - | - |
Ramucirumab | Phase 2 | Non-Small Cell Lung Cancer | - | - |
AZD4573 | Phase 2 | Advanced Haematological Malignancies | - | - |
MEDI0382 low dose | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
AZD0754 | Phase 2 | Metastatic Prostate Cancer | - | - |
AZD5069 | Phase 2 | Asthma | - | - |
AZD8683, 50 mcg | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
AZD9574 | Phase 2 | Advanced Solid Malignancies | - | - |
Formoterol fumarate (6 μg) | Phase 2 | Chronic Obstructive Pulmonary Disease - COPD | - | - |
Osimertinib 80 mg/40 mg | Phase 2 | Stage II-IIIB Non-small Cell Lung Carcinoma | - | - |
ZD1839 (IRESSA™) | Phase 2 | Head and Neck Cancer | - | - |
Exenatide LAR | Phase 2 | Type 2 Diabetes Mellitus | - | - |
plevitrexed | Phase 2 | Fallopian Tube Cancer | - | - |
AZD1981 | Phase 2 | Asthma | - | - |
AZD0865 | Phase 2 | GERD Without Erosive Esophagitis | - | - |
Atuliflapon | Phase 2 | Asthma | - | - |
AZD7789 | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
Aclidinium 400 μg / Formoterol 12 μg | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
MEDI3506 | Phase 2 | Atopic Dermatitis | - | - |
NXY-059 | Phase 2 | Intracerebral Hemorrhage | - | - |
CP-675,206 | Phase 2 | Malignant Melanoma | - | - |
GC012F (AZD0120) | Phase 2 | Relapsed/ Refractory Multiple Myeloma | - | - |
AZD8848 | Phase 2 | Allergic Asthma | - | - |
AZD7594 DPI 55μg/50μg. | Phase 2 | Asthma | - | - |
Iressa | Phase 2 | Locally Advanced Prostate Cancer | - | - |
AZD9164 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
AZD2936 | Phase 2 | Non-Small-Cell Lung Carcinoma | - | - |
AZD2281 | Phase 2 | Ovarian Neoplasms | - | - |
80/2.25 μg Symbicort pMDI | Phase 2 | Asthma | - | - |
Anastrozole and goserelin | Phase 2 | Breast Cancer | - | - |
AZD4360 | Phase 2 | Gastric Cancer | - | - |
Selumetinib 75 mg | Phase 2 | Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV | - | - |
Aclidinium/formoterol 400/12μg | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
MEDI4736 monotherapy | Phase 2 | Metastatic Pancreatic Ductal Adenocarcinoma | - | - |
Abiraterone | Phase 2 | Metastatic Castration-resistant Prostate Cancer | - | - |
IR (Immediate-Release) quetiapine fumarate (drug) | Phase 2 | Schizophrenia | - | - |
Mitiperstat (AZD4831) | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
AZD7798 | Phase 2 | Crohn's Disease | - | - |
Insulin | Phase 2 | Type 2 Diabetes Mellitus | - | - |
Fluorouracil (5-FU) | Phase 2 | Gastric Cancer | - | - |
AS MDI 90 μg | Phase 2 | Asthma | - | - |
D9421-C, 9mg | Phase 2 | Crohn's Disease | - | - |
AZD 8529 | Phase 2 | Schizophrenia | - | - |
5-flourouracil | Phase 2 | Squamous Cell Cancer | - | - |
AZD4635 | Phase 2 | Prostate Cancer | - | - |
5-Fluorouracil (5-FU) | Phase 2 | Gastroesophageal Adenocarcinoma | - | - |
Danvatirsen | Phase 2 | Non-Small Cell Lung Cancer | - | - |
AZD9291 | Phase 2 | Advanced Non Small Cell Lung Cancer | - | - |
MEDI2070 | Phase 2 | Crohn's Disease | - | - |
Temozolomide | Phase 2 | Melanoma | - | - |
AZD3355 | Phase 2 | GERD | - | - |
ICI35,868 (propofol) | Phase 2 | Gastrointestinal Endoscopy | - | - |
Ciclesonide/Formoterol Combination | Phase 2 | Asthma | - | - |
Olaparib Continuous (28-Day cycle) 300 mg BD. | Phase 2 | Metastatic Triple Negative Breast Cancer | - | - |
fostamatinib | Phase 2 | Rheumatoid Arthritis | - | - |
AZD7009, no generic name available | Phase 2 | Atrial Fibrillation | - | - |
AZD5069 50mg | Phase 2 | Scientific Terminology Chronic Obstructive Pulmonary Disease (COPD) | - | - |
AZD0901 | Phase 2 | Gastric Cancer | - | - |
AZD1446 | Phase 2 | Adult ADHD | - | - |
Salmeterol | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
Neoadjuvant Olaparib monotherapy group | Phase 2 | Breast Cancer | - | - |
AZD9829 | Phase 2 | Hematological Malignancies | - | - |
AZD5004 | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
LAS100977 0.313 μg | Phase 2 | Asthma | - | - |
AZD9773 | Phase 2 | Severe Sepsis | - | - |
Cotadutide | Phase 2 | Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis | - | - |
AZD2171 | Phase 2 | Metastatic Colorectal Cancer | - | - |
sibutramine | Phase 2 | Overweight | - | - |
Sodium Zirconium Cyclosilicate(ZS) | Phase 2 | Hyperkalemia | - | - |
AZD8931 | Phase 2 | Neoplasms | - | - |
AZD4017 | Phase 2 | Raised Intraocular Pressure | - | - |
Interferon beta-1a Nebuliser solution 48 μg/mL | Phase 2 | Asthma | - | - |
FOLFIRI (Fluorouracil (5-FU), leucovorin, irinotecan) | Phase 2 | Metastatic Colorectal Cancer | - | - |
CIN-107 | Phase 2 | Uncontrolled Hypertension | - | - |
budesonide/formoterol, 2x 200/6 microgram. 4 times daily | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
Cotadutide 100 micrograms | Phase 2 | Type 2 Diabetes Mellitus | - | - |
Durvalumab and Tremelimumab | Phase 2 | Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma | - | - |
Aclidinium 200 μg / formoterol 12 μg | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
Pramlintide and Metreleptin | Phase 2 | Obesity | - | - |
BMS-512148 | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
AZD3241 | Phase 2 | Multiple System Atrophy, MSA | - | - |
AZD2693 | Phase 2 | Nonalcoholic Steatohepatitis | - | - |
AZD4901 (oral) | Phase 2 | Polycystic Ovary Syndrome (PCOS), Female Endocrine Disorder | - | - |
MEDI7352 | Phase 2 | Painful Osteoarthritis of the Knee | - | - |
800 μg AZD7594 once daily | Phase 2 | Asthma | - | - |
MEDI-545 | Phase 2 | Systemic Lupus Erythematosus | - | - |
AZD0120 | Phase 2 | Lupus Erythematosus, Systemic | - | - |
AZD5718 | Phase 2 | Coronary Artery Disease | - | - |
Verinurad 9 mg+Febuxostat 80 mg | Phase 2 | Hyperuricemia | - | - |
exenatide (LY2148568) | Phase 2 | Type 2 Diabetes Mellitus | - | - |
0.5% Roflumilast Cream | Phase 2 | Atopic Dermatitis | - | - |
Verinurad | Phase 2 | Chronic Kidney Disease | - | - |
AZD8871 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
Epanova (4 g) and Lovaza (4 g) | Phase 2 | Severe Hypertriglyceridemia | - | - |
AZD2327 | Phase 2 | Anxious Major Depressive Disorder | - | - |
AZD9977 | Phase 2 | Heart Failure | - | - |
CP-675,206 and leuprolide acetate and bicalutamide | Phase 2 | Prostatic Neoplasms | - | - |
AZD0171 | Phase 2 | Locally Advanced or Metastatic Solid Tumours | - | - |
Osimertinib + Savolitinib | Phase 2 | Non-Small Cell Lung Cancer | - | - |
AZD0530 | Phase 2 | Breast Cancer | - | - |
AZD5305 | Phase 2 | Ovarian Cancer | - | - |
AZD8871 100 µg | Phase 2 | Chronic Obstructive Pulmonary Disease COPD | - | - |
Vinorelbine | Phase 2 | Non-Small Cell Lung Cancer | - | - |
AZD7648 | Phase 2 | Advanced Malignancies | - | - |
Gefitinib, Cisplatin and Radiotherapy | Phase 2 | Cancer of Head and Neck | - | - |
AZD4818 | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
VKA INR 2-3 | Phase 2 | Persistent or Permanent Nonvalvular Atrial Fibrillation | - | - |
AZD8421 | Phase 2 | ER+ HER2- Advanced Breast Cancer | - | - |
AZD1656 | Phase 2 | Type 2 Diabetes Mellitus | - | - |
AZD4512 | Phase 2 | B-cell Non-Hodgkin Lymphoma | - | - |
Surovatamig | Phase 2 | B-cell Non-Hodgkin Lymphoma | - | - |
Tiotropium 18 μg once-daily | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Monalizumab | Phase 2 | Non-small Cell Lung Cancer | - | - |
AZD0486 | Phase 2 | Chronic Lymphocytic Leukaemia | - | - |
AZD1163 | Phase 2 | Rheumatoid Arthritis | - | - |
Asthma
1 drug in this indication
Obesity/Overweight
1 drug in this indication
Acute Myeloid Leukemia
1 drug in this indication
Diabetes Mellitus
1 drug in this indication
Coronary Heart Disease (CHD)
1 drug in this indication
Urothelial Bladder Cancer
1 drug in this indication
Diabetes Mellitus, Type 2
1 drug in this indication
Chronic Obstructive Pulmonary Disease
1 drug in this indication
Mesothelioma
1 drug in this indication
Anticancer Treatment
1 drug in this indication
Ovarian Cancer
1 drug in this indication
Gastrointestinal Hemorrhage
1 drug in this indication
Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)